Skip to main content
. 2012 Jun 8;12:63. doi: 10.1186/1471-2431-12-63

Table 3.

Differences between survivors without significant BPD and deceased or surviving infants with significant BPD

  SWsBPD
Deceased/Significant BPD
p-value*
(n = 299) (n = 116)
Year of birth
 
 
0.032
- 1997–2000
38 (58.5%)
27 (41.5%)
 
- 2001–2005
132 (74.2%)
46 (25.8%)
 
- 2006–2009
129 (75.0%)
43 (25.0%)
 
Gestational age (w)
27.6 (26.1-29.4)
25.4 (24.4-27.0)
<0.001
Birth weight (g)
850 (750–935)
680 (589–780)
<0.001
IUGR
112 (38.5%)
37 (34.9%)
0.515
Multiple gestation
102 (34.1%)
48 (41.4%)
0.167
Male gender
135 (45.2%)
63 (54.3%)
0.094
Chorioamnionitis
48 (16.1%)
33 (28.4%)
0.004
Antibiotics (mother)
167 (59.6%)
78 (69.6%)
0.065
Prenatal steroids
277 (95.2%)
97 (84.3%)
<0.001
Cesarean section
213 (72.0%)
53 (45.7%)
<0.001
Apgar at 1 minute ≤3
29 (9.7%)
37 (32.5%)
<0.001
Apgar at 5 minutes ≤6
29 (9.7%)
32 (28.3%)
<0.001
Umbilical artery pH
7.26 (7.17-7.31)
7.29 (7.19-7.32)
0.165
Resuscitation
 
 
<0.001
- Not performed
67 (22.4%)
6 (5.2%)
 
- Mask/IPPV + PEEP
121 (40.5%)
20 (17.2%)
 
- ET intubation
102 (34.1%)
79 (68.1%)
 
- ET Intubation +
 
 
 
chest compression +
 
 
 
epinephrine
9 (3.0%)
11 (9.5%)
 
CRIB
4 (1–6)
9 (7–13)
<0.001
RDS
146 (48.8%)
92 (79.3%)
<0.001
Mechanical ventilation
184 (61.5%)
116 (100%)
<0.001
Sepsis
124 (41.5%)
54 (46.6%)
0.349
NEC
17 (5.7%)
13 (11.2%)
0.052
IVH
52 (17.4%)
45 (38.8%)
<0.001
- Grades III/IV
11 (3.7%)
34 (29.3%)
<0.001
PVLM
6 (3.1%)
4 (4.5%)
0.536
PDA
105 (35.1%)
43 (37.1%)
0.710
- Surgical closure
25 (8.4%)
6 (5.2%)
0.268
Severe arterial
 
 
 
hypotension 10 (3.4%) 30 (26.1%) <0.001

CRIB: clinical risk index for babies; IUGR: intrauterine growth restriction; ET: endotracheal; RDS: respiratory distress syndrome; NEC: necrotizing enterocolitis; IVH: peri-intraventricular hemorrhage; PEEP: positive end expiratory pressure; PVLM: periventricular leukomalacia; PDA: patent ductus arteriosus; SWsBPD: survival without significant BPD.

Median (IQR: 25th-75th percentile), number (%).

* Mann–Whitney U or chi-square test.